Cuts FY25 revenue view to $10.3B-$10.4B from $10.4B-$10.5B, consensus $10.49B. Lowers FY25 operating margin view to 19.5%-20.5% from 20%-21%.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALC:
- ALC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Alcon’s Strategic Acquisition of Staar Surgical: A Buy Rating Amid Growth Prospects and Risk Mitigation
- Snap downgraded, Leidos upgraded: Wall Street’s top analyst calls
- Staar Surgical price target raised to $28 from $20 at Canaccord
- Alcon resumed with an Equal Weight at Wells Fargo